Is the S&P 500 Flashing a Bearish Divergence?
Unlock the power of divergence analysis! Join Dave as he breaks down what a bearish momentum divergence is and why...
Latest Post
Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina
Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) is pleased to announce that...
GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims – Commissions Updated Preliminary Economic Assessment
GMV Minerals Inc. (the ‘Company’ or ‘GMV’) (TSXV:GMV)(OTCQB:GMVMF) announces that it has elected to extend its exclusive initial five (5)...
Blue Sky Uranium Closes 1st Tranche & Increases Oversubscribed Non-Brokered Private Placement
Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) announces that due to high...
Osisko Metals Intersects 0.33% Cu Over 258 Metres at Gaspé
Includes 15.6 Metres Averaging 1.47% Cu and 8.5 g/t Ag E Zone Skarn Returns 29.7 Metres Averaging 1.92% Cu and...
Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada
Camp opening and logistics have commenced with geophysics and drilling to follow in the coming weeks Aston Bay Holdings Ltd....
Procter & Gamble to cut 7,000 jobs as part of broader restructuring
Procter & Gamble will cut 7,000 jobs, or roughly 15% of its non-manufacturing workforce, as part of a two-year restructuring...
‘He’s like Iron Man’: Jensen Huang lit up London Tech Week — and we were in the room
LONDON — Wherever Nvidia CEO Jensen Huang goes, excitement follows — this time, all the way to London Tech Week....
Nuclear Fuels Commences 2025 Kaycee Uranium Project Drill Program
CSE:NF OTCQX:NFUNF Nuclear Fuels Inc. (CSE: NF) (OTCQX: NFUNF) (‘Nuclear Fuels’ or the ‘Company ‘) announces the commencement of its...
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
